PER 0.00% 8.0¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-93

  1. 4,651 Posts.
    lightbulb Created with Sketch. 696
    Watching the presentation...sounds good...my only "issue"....how confident is ANP, they will get boys prepared to participate in the IIb trial re getting placebo? Kids/Drs and placebo...potential to open a real can of worms....otherwise, full steam ahead I reckon....
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.